| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.929 | 0.001 | 0.936 | Tyrosine 3 hydroxylase inhibitor | 0.936 0.001 DBMET02273 0.935 0.001 DBMET02274 0.857 0.001 DBMET02275 0.579 0.003 DBMET00559 | DBMET02273 | |
| 0.879 | 0.001 | 0.961 | Thyroid hormone alpha antagonist | 0.513 0.002 DBMET02273 0.196 0.003 DBMET02274 0.961 0.001 DBMET02275 0.337 0.002 DBMET00559 | DBMET02275 | |
| 0.815 | 0.001 | 0.815 | NMDA receptor subunit 3A antagonist | 0.75 0.002 DBMET02273 0.614 0.002 DBMET02274 0.651 0.002 DBMET02275 0.156 0.005 DBMET00559 | ||
| 0.782 | 0.005 | 0.909 | Thyroid hormone antagonist | 0.617 0.017 DBMET02273 0.464 0.04 DBMET02274 0.909 0.004 DBMET02275 0.196 0.166 DBMET00559 | DBMET02275 | |
| 0.727 | 0.006 | 0.817 | Cholesterol antagonist | 0.726 0.006 DBMET02273 0.676 0.01 DBMET02274 0.758 0.005 DBMET02275 0.817 0.004 DBMET00559 | DBMET00559 | |
| 0.719 | 0.003 | 0.719 | NMDA receptor antagonist | 0.704 0.003 DBMET02273 0.538 0.004 DBMET02274 0.584 0.004 DBMET02275 0.707 0.003 DBMET00559 | ||
| 0.71 | 0 | 0.78 | Thyroid hormone alpha agonist | 0.546 0.001 DBMET02273 0.339 0.001 DBMET02274 0.78 0 DBMET02275 0.506 0.001 DBMET00559 | DBMET02275 | |
| 0.706 | 0.001 | 0.81 | Thyroid hormone agonist | 0.592 0.001 DBMET02273 0.57 0.001 DBMET02274 0.728 0.001 DBMET02275 0.81 0.001 DBMET00559 | DBMET00559 | |
| 0.65 | 0.002 | 0.691 | NMDA receptor subunit 3B antagonist | 0.691 0.002 DBMET02273 0.531 0.002 DBMET02274 0.453 0.003 DBMET02275 0.105 0.01 DBMET00559 | DBMET02273 | |
| 0.635 | 0.001 | 0.764 | Sodium/bile acid cotransporter inhibitor | 0.544 0.003 DBMET02273 0.461 0.006 DBMET02274 0.764 0.001 DBMET02275 0.548 0.003 DBMET00559 | DBMET02275 | |
| 0.614 | 0.003 | 0.748 | Cystathionine beta-synthase inhibitor | 0.748 0.002 DBMET02273 0.729 0.002 DBMET02274 0.592 0.003 DBMET02275 0.213 0.022 DBMET00559 | DBMET02273 | |
| 0.607 | 0.016 | 0.761 | Angiogenesis inhibitor | 0.539 0.023 DBMET02273 0.325 0.081 DBMET02274 0.715 0.008 DBMET02275 0.761 0.006 DBMET00559 | DBMET00559 | |
| 0.574 | 0.001 | 0.681 | DOPA decarboxylase inhibitor | 0.681 0 DBMET02273 0.598 0.001 DBMET02274 0.407 0.001 DBMET02275 0.316 0.002 DBMET00559 | DBMET02273 | |
| 0.534 | 0.026 | 0.799 | Thyroid hormone beta antagonist | 0.374 0.061 DBMET02273 0.256 0.115 DBMET02274 0.799 0.005 DBMET02275 | DBMET02275 | |
| 0.476 | 0.001 | 0.626 | Thyroid hormone beta agonist | 0.352 0.001 DBMET02273 0.199 0.001 DBMET02274 0.626 0.001 DBMET02275 0.019 0.004 DBMET00559 | DBMET02275 | |
| 0.47 | 0.005 | 0.502 | 5 Hydroxytryptamine uptake stimulant | 0.497 0.004 DBMET02273 0.502 0.004 DBMET02274 0.359 0.023 DBMET02275 0.233 0.099 DBMET00559 | DBMET02274 | |
| 0.504 | 0.049 | 0.651 | Cyclophilin D inhibitor | 0.472 0.059 DBMET02273 0.385 0.1 DBMET02274 0.651 0.019 DBMET02275 0.425 0.078 DBMET00559 | DBMET02275 | |
| 0.454 | 0.019 | 0.463 | DNA damaging | 0.463 0.018 DBMET02273 0.355 0.039 DBMET02274 0.411 0.026 DBMET02275 0.238 0.087 DBMET00559 | DBMET02273 | |
| 0.434 | 0.017 | 0.655 | Angiogenesis stimulant | 0.391 0.023 DBMET02273 0.384 0.024 DBMET02274 0.401 0.021 DBMET02275 0.655 0.005 DBMET00559 | DBMET00559 | |
| 0.433 | 0.018 | 0.439 | Psychostimulant | 0.439 0.017 DBMET02273 0.435 0.018 DBMET02274 0.224 0.068 DBMET02275 | DBMET02273 | |
| 0.397 | 0.004 | 0.397 | Aminoacyl-tRNA synthetase inhibitor | 0.383 0.004 DBMET02273 0.376 0.004 DBMET02274 0.332 0.005 DBMET02275 0.353 0.005 DBMET00559 | ||
| 0.444 | 0.054 | 0.479 | Transcription factor NF kappa B inhibitor | 0.479 0.047 DBMET02273 0.479 0.047 DBMET02274 0.409 0.061 DBMET02275 0.302 0.093 DBMET00559 | DBMET02274 | |
| 0.379 | 0.004 | 0.392 | Farnesoid X receptor antagonist | 0.357 0.004 DBMET02273 0.263 0.01 DBMET02274 0.392 0.004 DBMET02275 0.316 0.005 DBMET00559 | DBMET02275 | |
| 0.385 | 0.028 | 0.562 | Hypolipemic | 0.282 0.055 DBMET02273 0.562 0.008 DBMET02275 0.203 0.092 DBMET00559 | DBMET02275 | |
| 0.352 | 0.003 | 0.457 | Phenylalanine 4-hydroxylase inhibitor | 0.457 0.003 DBMET02273 0.457 0.003 DBMET02274 0.18 0.008 DBMET02275 0.15 0.012 DBMET00559 | DBMET02274 | |
| 0.437 | 0.097 | 0.486 | Apoptosis agonist | 0.455 0.089 DBMET02273 0.299 0.173 DBMET02274 0.486 0.079 DBMET02275 | DBMET02275 | |
| 0.346 | 0.007 | 0.368 | Glutamate receptor antagonist | 0.368 0.006 DBMET02273 0.288 0.011 DBMET02274 0.173 0.037 DBMET02275 0.275 0.012 DBMET00559 | DBMET02273 | |
| 0.361 | 0.041 | 0.385 | Interleukin 2 agonist | 0.385 0.032 DBMET02273 0.381 0.034 DBMET02274 0.273 0.095 DBMET02275 0.267 0.1 DBMET00559 | DBMET02273 | |
| 0.319 | 0.002 | 0.337 | Purinergic P2X2 antagonist | 0.232 0.003 DBMET02273 0.229 0.004 DBMET02274 0.337 0.001 DBMET02275 0.294 0.002 DBMET00559 | DBMET02275 | |
| 0.314 | 0.005 | 0.362 | Glutamate dehydrogenase inhibitor | 0.362 0.004 DBMET02273 0.35 0.005 DBMET02274 0.169 0.013 DBMET02275 0.182 0.012 DBMET00559 | DBMET02273 | |
| 0.3 | 0.004 | 0.494 | NMDA 2A receptor antagonist | 0.489 0.003 DBMET02273 0.494 0.003 DBMET02274 0.142 0.008 DBMET02275 0.211 0.005 DBMET00559 | DBMET02274 | |
| 0.326 | 0.032 | 0.454 | Peroxidase inhibitor | 0.454 0.014 DBMET02273 0.431 0.016 DBMET02274 0.134 0.088 DBMET02275 | DBMET02273 | |
| 0.299 | 0.006 | 0.397 | Histidine decarboxylase inhibitor | 0.397 0.004 DBMET02273 0.393 0.004 DBMET02274 | DBMET02273 | |
| 0.32 | 0.073 | 0.421 | Immunostimulant | 0.387 0.054 DBMET02273 0.421 0.044 DBMET02274 0.209 0.115 DBMET02275 0.409 0.047 DBMET00559 | DBMET02274 | |
| 0.25 | 0.004 | 0.25 | Somatostatin 1 agonist | 0.192 0.007 DBMET02273 0.189 0.008 DBMET02274 0.233 0.005 DBMET02275 0.13 0.019 DBMET00559 | ||
| 0.296 | 0.052 | 0.426 | Superoxide dismutase inhibitor | 0.402 0.026 DBMET02273 0.406 0.026 DBMET02274 0.192 0.126 DBMET02275 0.426 0.022 DBMET00559 | DBMET00559 | |
| 0.306 | 0.063 | 0.408 | Hypoxia-inducible factor 1 alpha inhibitor | 0.254 0.097 DBMET02273 0.408 0.028 DBMET02275 | DBMET02275 | |
| 0.244 | 0.003 | 0.3 | Glutamate (mGluR3) antagonist | 0.298 0.003 DBMET02273 0.3 0.003 DBMET02274 0.067 0.007 DBMET02275 0.038 0.024 DBMET00559 | DBMET02274 | |
| 0.315 | 0.076 | 0.377 | Vasodilator, coronary | 0.377 0.043 DBMET02273 0.376 0.044 DBMET02274 0.357 0.052 DBMET02275 | DBMET02273 | |
| 0.244 | 0.014 | 0.306 | Aminopeptidase B inhibitor | 0.274 0.01 DBMET02273 0.273 0.011 DBMET02274 0.147 0.039 DBMET02275 0.306 0.008 DBMET00559 | DBMET00559 | |
| 0.233 | 0.004 | 0.306 | Bile acid receptor antagonist | 0.244 0.004 DBMET02273 0.189 0.005 DBMET02274 0.306 0.003 DBMET02275 0.26 0.003 DBMET00559 | DBMET02275 | |
| 0.288 | 0.062 | 0.316 | Cardiotonic | 0.316 0.05 DBMET02273 0.164 0.159 DBMET02274 0.306 0.054 DBMET02275 | DBMET02273 | |
| 0.308 | 0.083 | 0.523 | Antithrombotic | 0.395 0.05 DBMET02273 0.395 0.05 DBMET02274 0.385 0.053 DBMET02275 0.523 0.026 DBMET00559 | DBMET00559 | |
| 0.236 | 0.017 | 0.236 | Cell adhesion inhibitor | 0.226 0.019 DBMET02273 0.222 0.019 DBMET02274 0.162 0.04 DBMET02275 0.171 0.035 DBMET00559 | ||
| 0.238 | 0.018 | 0.298 | Chelator | 0.298 0.011 DBMET02273 0.193 0.026 DBMET02274 0.232 0.019 DBMET02275 | DBMET02273 | |
| 0.241 | 0.033 | 0.358 | Protein-tyrosine phosphatase inhibitor | 0.264 0.027 DBMET02273 0.26 0.028 DBMET02274 0.274 0.025 DBMET02275 0.358 0.011 DBMET00559 | DBMET00559 | |
| 0.25 | 0.043 | 0.289 | Growth hormone agonist | 0.289 0.034 DBMET02273 0.289 0.034 DBMET02274 0.204 0.057 DBMET02275 0.126 0.111 DBMET00559 | DBMET02274 | |
| 0.213 | 0.008 | 0.411 | NMDA 2 receptor antagonist | 0.398 0.004 DBMET02273 0.411 0.004 DBMET02274 0.108 0.028 DBMET02275 0.407 0.004 DBMET00559 | DBMET02274 | |
| 0.233 | 0.029 | 0.336 | Succinate dehydrogenase inhibitor | 0.249 0.023 DBMET02273 0.241 0.026 DBMET02274 0.336 0.006 DBMET02275 0.169 0.081 DBMET00559 | DBMET02275 | |
| 0.198 | 0.004 | 0.356 | GABA aminotransferase inhibitor | 0.344 0.003 DBMET02273 0.356 0.003 DBMET02274 0.187 0.005 DBMET02275 0.068 0.065 DBMET00559 | DBMET02274 | |
| 0.19 | 0.004 | 0.19 | Growth hormone release inhibitor | 0.08 0.009 DBMET02273 0.078 0.01 DBMET02274 0.17 0.004 DBMET02275 0.046 0.025 DBMET00559 | ||
| 0.188 | 0.008 | 0.374 | Peroxisome proliferator-activated receptor gamma agonist | 0.142 0.015 DBMET02273 0.127 0.018 DBMET02274 0.374 0.004 DBMET02275 0.077 0.043 DBMET00559 | DBMET02275 | |
| 0.184 | 0.005 | 0.268 | NMDA receptor agonist | 0.223 0.004 DBMET02273 0.221 0.004 DBMET02274 0.11 0.016 DBMET02275 0.268 0.004 DBMET00559 | DBMET00559 | |
| 0.306 | 0.131 | 0.492 | Antibacterial | 0.364 0.094 DBMET02273 0.334 0.111 DBMET02274 0.287 0.145 DBMET02275 0.492 0.043 DBMET00559 | DBMET00559 | |
| 0.195 | 0.021 | 0.252 | GABA C receptor agonist | 0.223 0.017 DBMET02273 0.195 0.021 DBMET02274 0.252 0.013 DBMET02275 | DBMET02275 | |
| 0.188 | 0.015 | 0.21 | Vanilloid 1 agonist | 0.187 0.016 DBMET02273 0.189 0.015 DBMET02274 0.21 0.01 DBMET02275 0.161 0.029 DBMET00559 | DBMET02275 | |
| 0.182 | 0.009 | 0.24 | Glutamate decarboxylase inhibitor | 0.24 0.005 DBMET02273 0.236 0.005 DBMET02274 0.129 0.018 DBMET02275 0.094 0.033 DBMET00559 | DBMET02273 | |
| 0.314 | 0.149 | 0.393 | 5 Hydroxytryptamine release inhibitor | 0.391 0.084 DBMET02273 0.393 0.082 DBMET02274 0.281 0.188 DBMET02275 | DBMET02274 | |
| 0.25 | 0.089 | 0.394 | 5 Hydroxytryptamine release stimulant | 0.394 0.047 DBMET02273 0.379 0.05 DBMET02274 | DBMET02273 | |
| 0.191 | 0.031 | 0.232 | Protein-tyrosine phosphatase 1B inhibitor | 0.207 0.027 DBMET02273 0.205 0.028 DBMET02274 0.224 0.023 DBMET02275 0.232 0.02 DBMET00559 | DBMET00559 | |
| 0.195 | 0.036 | 0.221 | Alpha-N-acetylglucosaminidase inhibitor | 0.221 0.028 DBMET02273 0.22 0.029 DBMET02274 0.216 0.03 DBMET02275 | DBMET02273 | |
| 0.224 | 0.067 | 0.349 | Amyloid beta aggregation inhibitor | 0.349 0.035 DBMET02273 0.348 0.035 DBMET02274 0.232 0.064 DBMET02275 | DBMET02273 | |
| 0.175 | 0.02 | 0.242 | Catalase inhibitor | 0.21 0.013 DBMET02273 0.203 0.015 DBMET02274 0.064 0.061 DBMET02275 0.242 0.009 DBMET00559 | DBMET00559 | |
| 0.174 | 0.02 | 0.201 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.201 0.016 DBMET02273 0.201 0.015 DBMET02274 0.173 0.021 DBMET02275 | DBMET02274 | |
| 0.155 | 0.004 | 0.205 | Vitronectin receptor antagonist | 0.096 0.005 DBMET02273 0.025 0.012 DBMET02274 0.205 0.004 DBMET02275 0.038 0.008 DBMET00559 | DBMET02275 | |
| 0.154 | 0.004 | 0.241 | AMPA 4 receptor antagonist | 0.241 0.003 DBMET02273 0.226 0.003 DBMET02274 0.043 0.022 DBMET02275 | DBMET02273 | |
| 0.154 | 0.004 | 0.175 | AMPA 2 receptor antagonist | 0.175 0.004 DBMET02273 0.168 0.004 DBMET02274 0.049 0.011 DBMET00559 | DBMET02273 | |
| 0.153 | 0.004 | 0.191 | Glutamate (mGluR4) antagonist | 0.19 0.003 DBMET02273 0.191 0.003 DBMET02274 0.053 0.018 DBMET02275 0.047 0.025 DBMET00559 | DBMET02274 | |
| 0.152 | 0.004 | 0.195 | Glutamate (mGluR group III) antagonist | 0.195 0.003 DBMET02273 0.194 0.003 DBMET02274 0.054 0.017 DBMET02275 0.042 0.034 DBMET00559 | DBMET02273 | |
| 0.175 | 0.031 | 0.203 | Cathepsin H inhibitor | 0.201 0.022 DBMET02273 0.203 0.022 DBMET02274 0.119 0.076 DBMET02275 0.127 0.067 DBMET00559 | DBMET02274 | |
| 0.228 | 0.085 | 0.271 | DNA synthesis inhibitor | 0.271 0.055 DBMET02273 0.256 0.063 DBMET02274 0.205 0.116 DBMET02275 | DBMET02273 | |
| 0.186 | 0.044 | 0.226 | Neurotensin receptor agonist | 0.226 0.025 DBMET02273 0.225 0.026 DBMET02274 | DBMET02273 | |
| 0.153 | 0.012 | 0.181 | Aminopeptidase I inhibitor | 0.18 0.008 DBMET02273 0.181 0.008 DBMET02274 0.116 0.021 DBMET02275 0.078 0.044 DBMET00559 | DBMET02274 | |
| 0.143 | 0.002 | 0.163 | Kainate receptor agonist | 0.163 0.002 DBMET02273 0.156 0.002 DBMET02274 0.055 0.01 DBMET02275 0.064 0.005 DBMET00559 | DBMET02273 | |
| 0.19 | 0.051 | 0.246 | Phospholipase C inhibitor | 0.243 0.026 DBMET02273 0.246 0.026 DBMET02274 0.174 0.068 DBMET02275 0.23 0.03 DBMET00559 | DBMET02274 | |
| 0.141 | 0.005 | 0.211 | Kainate receptor antagonist | 0.211 0.004 DBMET02273 0.206 0.004 DBMET02274 0.056 0.018 DBMET00559 | DBMET02273 | |
| 0.138 | 0.004 | 0.155 | Glutamate (mGluR7) antagonist | 0.155 0.003 DBMET02273 0.152 0.003 DBMET02274 0.107 0.008 DBMET02275 0.072 0.04 DBMET00559 | DBMET02273 | |
| 0.139 | 0.008 | 0.157 | Glycine receptor agonist | 0.157 0.006 DBMET02273 0.148 0.007 DBMET02274 0.136 0.009 DBMET02275 0.075 0.045 DBMET00559 | DBMET02273 | |
| 0.14 | 0.013 | 0.161 | Argininosuccinate synthase inhibitor | 0.161 0.01 DBMET02273 0.153 0.011 DBMET02274 0.056 0.041 DBMET02275 | DBMET02273 | |
| 0.209 | 0.091 | 0.307 | Free radical scavenger | 0.307 0.05 DBMET02273 0.303 0.051 DBMET02274 0.23 0.078 DBMET02275 0.154 0.14 DBMET00559 | DBMET02273 | |
| 0.129 | 0.014 | 0.139 | Ribonucleoside-diphosphate reductase inhibitor | 0.139 0.013 DBMET02273 0.136 0.013 DBMET02274 0.089 0.022 DBMET02275 | DBMET02273 | |
| 0.128 | 0.015 | 0.197 | Vanilloid agonist | 0.107 0.026 DBMET02273 0.107 0.026 DBMET02274 0.197 0.007 DBMET02275 0.113 0.022 DBMET00559 | DBMET02275 | |
| 0.195 | 0.084 | 0.323 | Pyruvate kinase inhibitor | 0.321 0.042 DBMET02273 0.323 0.042 DBMET02274 | DBMET02274 | |
| 0.116 | 0.006 | 0.126 | Glutamate (mGluR6) antagonist | 0.126 0.005 DBMET02273 0.123 0.005 DBMET02274 0.08 0.024 DBMET02275 0.065 0.052 DBMET00559 | DBMET02273 | |
| 0.129 | 0.019 | 0.203 | Keratolytic | 0.2 0.008 DBMET02273 0.203 0.008 DBMET02274 0.133 0.018 DBMET02275 | DBMET02274 | |
| 0.124 | 0.016 | 0.133 | Ribonucleotide reductase inhibitor | 0.133 0.014 DBMET02273 0.131 0.015 DBMET02274 0.089 0.024 DBMET02275 | DBMET02273 | |
| 0.227 | 0.12 | 0.289 | Insulysin inhibitor | 0.286 0.068 DBMET02273 0.289 0.066 DBMET02274 0.236 0.11 DBMET02275 | DBMET02274 | |
| 0.188 | 0.086 | 0.226 | Insulin sensitizer | 0.223 0.052 DBMET02273 0.226 0.05 DBMET02274 0.192 0.082 DBMET02275 | DBMET02274 | |
| 0.138 | 0.039 | 0.232 | Photosensitizer | 0.171 0.021 DBMET02273 0.164 0.024 DBMET02274 0.232 0.008 DBMET02275 | DBMET02275 | |
| 0.14 | 0.041 | 0.161 | DNA repair enzyme inhibitor | 0.161 0.023 DBMET02273 0.135 0.048 DBMET02274 0.149 0.032 DBMET02275 | DBMET02273 | |
| 0.103 | 0.005 | 0.103 | Somatostatin 5 agonist | 0.057 0.01 DBMET02273 0.056 0.01 DBMET02274 0.079 0.006 DBMET02275 | ||
| 0.167 | 0.07 | 0.24 | Thrombolytic | 0.205 0.049 DBMET02273 0.202 0.051 DBMET02274 0.24 0.036 DBMET00559 | DBMET00559 | |
| 0.101 | 0.005 | 0.119 | Kainate receptor 2 antagonist | 0.119 0.004 DBMET02273 0.114 0.004 DBMET02274 0.035 0.025 DBMET02275 | DBMET02273 | |
| 0.13 | 0.036 | 0.144 | Adenylate kinase inhibitor | 0.144 0.029 DBMET02273 0.136 0.033 DBMET02274 0.125 0.04 DBMET02275 0.097 0.073 DBMET00559 | DBMET02273 | |
| 0.107 | 0.014 | 0.183 | NMDA 2C receptor antagonist | 0.183 0.005 DBMET02273 0.18 0.005 DBMET02274 0.074 0.03 DBMET02275 0.118 0.011 DBMET00559 | DBMET02273 | |
| 0.134 | 0.042 | 0.175 | Nav1.4 sodium channel blocker | 0.156 0.031 DBMET02273 0.154 0.032 DBMET02274 0.121 0.051 DBMET02275 0.175 0.025 DBMET00559 | DBMET00559 | |
| 0.117 | 0.026 | 0.151 | Opioid delta receptor antagonist | 0.151 0.019 DBMET02273 0.148 0.02 DBMET02274 | DBMET02273 | |
| 0.194 | 0.104 | 0.355 | Antiamyloidogenic | 0.354 0.038 DBMET02273 0.355 0.038 DBMET02274 | DBMET02274 | |
| 0.094 | 0.006 | 0.097 | VLA-4 antagonist | 0.097 0.006 DBMET02273 0.095 0.006 DBMET02274 | DBMET02273 | |
| 0.106 | 0.019 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.118 0.016 DBMET02273 0.106 0.019 DBMET02274 0.082 0.028 DBMET02275 0.07 0.035 DBMET00559 | DBMET02273 | |
| 0.132 | 0.044 | 0.16 | Mucolytic | 0.16 0.027 DBMET02273 0.156 0.029 DBMET02274 0.096 0.083 DBMET02275 | DBMET02273 | |
| 0.103 | 0.018 | 0.125 | Carbonic anhydrase stimulant | 0.125 0.014 DBMET02273 0.123 0.014 DBMET02274 0.055 0.046 DBMET00559 | DBMET02273 | |
| 0.111 | 0.028 | 0.131 | Phosphofructokinase-1 inhibitor | 0.126 0.023 DBMET02273 0.116 0.026 DBMET02274 0.131 0.022 DBMET02275 | DBMET02275 | |
| 0.084 | 0.004 | 0.127 | Kainate receptor 1 antagonist | 0.127 0.003 DBMET02273 0.121 0.003 DBMET02274 | DBMET02273 | |
| 0.105 | 0.026 | 0.271 | Selectin antagonist | 0.131 0.02 DBMET02273 0.125 0.021 DBMET02274 0.1 0.028 DBMET02275 0.271 0.007 DBMET00559 | DBMET00559 | |
| 0.095 | 0.017 | 0.099 | 5 Hydroxytryptamine 2A agonist | 0.099 0.015 DBMET02273 0.097 0.016 DBMET02274 | DBMET02273 | |
| 0.115 | 0.038 | 0.138 | Opioid antagonist | 0.138 0.029 DBMET02273 0.136 0.03 DBMET02274 | DBMET02273 | |
| 0.094 | 0.017 | 0.106 | Ornithine carbamoyltransferase inhibitor | 0.106 0.015 DBMET02273 0.1 0.016 DBMET02274 0.061 0.031 DBMET00559 | DBMET02273 | |
| 0.078 | 0.002 | 0.087 | Tryptophan hydroxylase 1 inhibitor | 0.087 0.002 DBMET02273 0.082 0.002 DBMET02274 0.044 0.003 DBMET00559 | DBMET02273 | |
| 0.104 | 0.03 | 0.121 | Opioid mu receptor antagonist | 0.121 0.024 DBMET02273 0.119 0.025 DBMET02274 | DBMET02273 | |
| 0.083 | 0.008 | 0.103 | Leukotriene A4 hydrolase inhibitor | 0.103 0.005 DBMET02273 0.102 0.005 DBMET02274 0.074 0.01 DBMET02275 | DBMET02273 | |
| 0.077 | 0.004 | 0.081 | AMPA receptor agonist | 0.081 0.004 DBMET02273 0.079 0.004 DBMET02274 0.057 0.006 DBMET00559 | DBMET02273 | |
| 0.108 | 0.036 | 0.126 | Ornithine decarboxylase inhibitor | 0.124 0.023 DBMET02273 0.126 0.021 DBMET02274 0.1 0.044 DBMET02275 | DBMET02274 | |
| 0.093 | 0.02 | 0.104 | NMDA receptor glycine site agonist | 0.104 0.014 DBMET02273 0.104 0.015 DBMET02274 0.095 0.019 DBMET02275 | DBMET02274 | |
| 0.083 | 0.011 | 0.101 | Epithelial sodium channel blocker | 0.086 0.01 DBMET02273 0.087 0.01 DBMET02274 0.101 0.007 DBMET02275 | DBMET02275 | |
| 0.114 | 0.043 | 0.159 | Prolactin inhibitor | 0.159 0.019 DBMET02273 0.151 0.022 DBMET02274 0.082 0.078 DBMET02275 | DBMET02273 | |
| 0.187 | 0.118 | 0.211 | Peptidyltransferase inhibitor | 0.211 0.086 DBMET02273 0.21 0.087 DBMET02274 | DBMET02273 | |
| 0.142 | 0.074 | 0.259 | Protein kinase stimulant | 0.203 0.041 DBMET02273 0.201 0.041 DBMET02274 0.259 0.024 DBMET02275 | DBMET02275 | |
| 0.073 | 0.005 | 0.106 | Purinergic P2X3 antagonist | 0.106 0.004 DBMET02275 0.032 0.029 DBMET00559 | DBMET02275 | |
| 0.143 | 0.075 | 0.161 | Adenylate cyclase stimulant | 0.161 0.047 DBMET02273 0.158 0.051 DBMET02274 0.149 0.064 DBMET02275 0.133 0.094 DBMET00559 | DBMET02273 | |
| 0.106 | 0.042 | 0.29 | Triose-phosphate isomerase inhibitor | 0.118 0.034 DBMET02273 0.116 0.035 DBMET02274 0.184 0.013 DBMET02275 0.29 0.005 DBMET00559 | DBMET00559 | |
| 0.101 | 0.039 | 0.116 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET02273 0.105 0.034 DBMET02274 0.116 0.022 DBMET02275 | DBMET02275 | |
| 0.081 | 0.019 | 0.104 | Integrin antagonist | 0.104 0.016 DBMET02273 0.1 0.016 DBMET02274 | DBMET02273 | |
| 0.07 | 0.008 | 0.081 | Fumarate hydratase inhibitor | 0.081 0.007 DBMET02273 0.073 0.008 DBMET02274 0.07 0.008 DBMET02275 | DBMET02273 | |
| 0.066 | 0.005 | 0.193 | NMDA 2D receptor antagonist | 0.076 0.004 DBMET02273 0.075 0.005 DBMET02274 0.052 0.007 DBMET02275 0.193 0.003 DBMET00559 | DBMET00559 | |
| 0.066 | 0.005 | 0.073 | Glutamate (mGluR8) agonist | 0.073 0.004 DBMET02273 0.071 0.005 DBMET02274 0.039 0.024 DBMET02275 | DBMET02273 | |
| 0.065 | 0.004 | 0.068 | Glutamate (mGluR8) antagonist | 0.068 0.004 DBMET02273 0.067 0.004 DBMET02274 0.037 0.022 DBMET02275 0.049 0.009 DBMET00559 | DBMET02273 | |
| 0.068 | 0.009 | 0.068 | Somatostatin 5 antagonist | 0.042 0.017 DBMET02273 0.042 0.017 DBMET02274 0.05 0.013 DBMET02275 | ||
| 0.088 | 0.029 | 0.089 | Glucagon-like peptide 1 agonist | 0.089 0.029 DBMET02273 0.088 0.029 DBMET02274 0.067 0.043 DBMET02275 | DBMET02273 | |
| 0.062 | 0.004 | 0.071 | Tryptophan 5 hydroxylase inhibitor | 0.069 0.003 DBMET02273 0.071 0.003 DBMET02274 0.039 0.017 DBMET00559 | DBMET02274 | |
| 0.111 | 0.054 | 0.162 | Carbonic anhydrase XV inhibitor | 0.161 0.027 DBMET02273 0.162 0.027 DBMET02274 0.122 0.045 DBMET02275 | DBMET02274 | |
| 0.066 | 0.01 | 0.066 | Somatostatin 2 antagonist | 0.034 0.019 DBMET02273 0.031 0.02 DBMET02274 0.041 0.017 DBMET02275 | ||
| 0.064 | 0.009 | 0.076 | Integrin alpha4 antagonist | 0.076 0.008 DBMET02273 0.073 0.008 DBMET02274 | DBMET02273 | |
| 0.066 | 0.013 | 0.066 | Somatostatin 1 antagonist | 0.042 0.025 DBMET02273 0.041 0.025 DBMET02274 0.044 0.023 DBMET02275 | ||
| 0.106 | 0.053 | 0.149 | Creatine kinase inhibitor | 0.149 0.024 DBMET02273 0.143 0.027 DBMET02274 0.123 0.039 DBMET02275 | DBMET02273 | |
| 0.057 | 0.005 | 0.066 | Kainate receptor 5 antagonist | 0.066 0.005 DBMET02273 0.061 0.005 DBMET02274 0.026 0.011 DBMET00559 | DBMET02273 | |
| 0.093 | 0.041 | 0.109 | Chymotrypsin inhibitor | 0.108 0.031 DBMET02273 0.109 0.031 DBMET02274 0.087 0.047 DBMET02275 0.109 0.031 DBMET00559 | DBMET00559 | |
| 0.058 | 0.006 | 0.083 | AMPA 3 receptor antagonist | 0.083 0.004 DBMET02273 0.076 0.005 DBMET02274 | DBMET02273 | |
| 0.125 | 0.075 | 0.159 | Tubulin antagonist | 0.131 0.07 DBMET02273 0.159 0.054 DBMET02275 | DBMET02275 | |
| 0.076 | 0.026 | 0.13 | Prostaglandin F2 alpha antagonist | 0.085 0.019 DBMET02273 0.084 0.02 DBMET02274 0.13 0.005 DBMET02275 | DBMET02275 | |
| 0.183 | 0.134 | 0.315 | Spasmolytic | 0.308 0.067 DBMET02273 0.315 0.065 DBMET02274 0.179 0.138 DBMET02275 | DBMET02274 | |
| 0.054 | 0.007 | 0.059 | VCAM-1 antagonist | 0.059 0.005 DBMET02273 0.059 0.005 DBMET02274 0.043 0.018 DBMET02275 0.038 0.031 DBMET00559 | DBMET02274 | |
| 0.053 | 0.007 | 0.059 | VCAM antagonist | 0.059 0.005 DBMET02273 0.058 0.005 DBMET02274 0.043 0.018 DBMET02275 0.038 0.031 DBMET00559 | DBMET02273 | |
| 0.051 | 0.007 | 0.057 | Kainate receptor 4 antagonist | 0.057 0.005 DBMET02273 0.052 0.006 DBMET02274 | DBMET02273 | |
| 0.052 | 0.008 | 0.052 | Somatostatin 4 antagonist | 0.024 0.017 DBMET02273 0.023 0.017 DBMET02274 0.033 0.01 DBMET02275 | ||
| 0.086 | 0.043 | 0.336 | Porphobilinogen synthase inhibitor | 0.106 0.033 DBMET02273 0.099 0.037 DBMET02274 0.336 0.005 DBMET02275 | DBMET02275 | |
| 0.089 | 0.046 | 0.098 | D-Ala-D-Ala ligase inhibitor | 0.091 0.043 DBMET02273 0.092 0.041 DBMET02274 0.098 0.032 DBMET02275 | DBMET02275 | |
| 0.069 | 0.026 | 0.077 | Botulinum neurotoxin type A inhibitor | 0.076 0.02 DBMET02273 0.077 0.019 DBMET02274 0.054 0.048 DBMET02275 | DBMET02274 | |
| 0.054 | 0.013 | 0.155 | Retinoid X alpha receptor agonist | 0.044 0.017 DBMET02273 0.032 0.028 DBMET02274 0.155 0.003 DBMET02275 | DBMET02275 | |
| 0.057 | 0.016 | 0.072 | AICAR transformylase inhibitor | 0.069 0.01 DBMET02273 0.07 0.01 DBMET02274 0.072 0.009 DBMET02275 0.046 0.028 DBMET00559 | DBMET02275 | |
| 0.15 | 0.11 | 0.195 | Hepatoprotectant | 0.184 0.076 DBMET02273 0.181 0.079 DBMET02274 0.195 0.068 DBMET00559 | DBMET00559 | |
| 0.072 | 0.031 | 0.103 | Beta 3 adrenoreceptor antagonist | 0.099 0.015 DBMET02273 0.101 0.014 DBMET02274 0.103 0.014 DBMET02275 | DBMET02275 | |
| 0.071 | 0.031 | 0.082 | Aminopeptidase microsomal inhibitor | 0.082 0.024 DBMET02273 0.081 0.024 DBMET02274 | DBMET02273 | |
| 0.064 | 0.026 | 0.077 | Urokinase inhibitor | 0.077 0.022 DBMET02273 0.076 0.022 DBMET02274 | DBMET02273 | |
| 0.178 | 0.141 | 0.227 | Interleukin agonist | 0.227 0.097 DBMET02273 0.226 0.098 DBMET02274 | DBMET02273 | |
| 0.068 | 0.03 | 0.12 | Alcohol oxidase inhibitor | 0.12 0.014 DBMET02273 0.108 0.016 DBMET02274 0.087 0.022 DBMET02275 | DBMET02273 | |
| 0.044 | 0.007 | 0.052 | Glutamate (mGluR3) agonist | 0.052 0.004 DBMET02273 0.052 0.004 DBMET02274 | DBMET02274 | |
| 0.04 | 0.004 | 0.061 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.022 0.007 DBMET02273 0.021 0.007 DBMET02274 0.061 0.004 DBMET02275 0.014 0.011 DBMET00559 | DBMET02275 | |
| 0.102 | 0.067 | 0.132 | Expectorant | 0.132 0.043 DBMET02273 0.128 0.046 DBMET02274 | DBMET02273 | |
| 0.059 | 0.024 | 0.085 | Beta 2 adrenoreceptor antagonist | 0.08 0.012 DBMET02273 0.08 0.012 DBMET02274 0.085 0.01 DBMET02275 | DBMET02275 | |
| 0.097 | 0.062 | 0.147 | Interleukin 1 beta converting enzyme inhibitor | 0.128 0.029 DBMET02273 0.128 0.029 DBMET02274 0.147 0.018 DBMET02275 | DBMET02275 | |
| 0.11 | 0.076 | 0.152 | Adenylate cyclase inhibitor | 0.152 0.044 DBMET02273 0.152 0.044 DBMET02274 | DBMET02274 | |
| 0.041 | 0.008 | 0.041 | Somatostatin 3 antagonist | 0.026 0.01 DBMET02275 | ||
| 0.093 | 0.06 | 0.162 | Alcohol dehydrogenase inhibitor | 0.138 0.025 DBMET02273 0.136 0.025 DBMET02274 0.162 0.017 DBMET02275 | DBMET02275 | |
| 0.044 | 0.011 | 0.131 | Sigma 1 receptor antagonist | 0.131 0.005 DBMET02275 | DBMET02275 | |
| 0.061 | 0.029 | 0.063 | Angiotensin-converting enzyme inhibitor | 0.063 0.026 DBMET02273 0.063 0.027 DBMET02274 | DBMET02274 | |
| 0.142 | 0.111 | 0.194 | Amyloid beta precursor protein antagonist | 0.193 0.062 DBMET02273 0.193 0.062 DBMET02274 0.194 0.061 DBMET02275 | DBMET02275 | |
| 0.057 | 0.026 | 0.093 | Phosphorylase inhibitor | 0.093 0.014 DBMET02273 0.092 0.014 DBMET02274 0.039 0.038 DBMET00559 | DBMET02273 | |
| 0.097 | 0.068 | 0.111 | Protease inhibitor | 0.111 0.055 DBMET02273 0.111 0.056 DBMET02274 | DBMET02274 | |
| 0.083 | 0.054 | 0.137 | Adrenaline agonist | 0.135 0.019 DBMET02273 0.137 0.018 DBMET02274 0.098 0.038 DBMET02275 | DBMET02274 | |
| 0.041 | 0.014 | 0.082 | AMPA 1 receptor antagonist | 0.082 0.007 DBMET02273 0.072 0.008 DBMET02274 | DBMET02273 | |
| 0.063 | 0.037 | 0.072 | Plasminogen activator inhibitor | 0.072 0.03 DBMET02273 0.072 0.03 DBMET02274 | DBMET02274 | |
| 0.063 | 0.037 | 0.073 | Beta 2 adrenoreceptor agonist | 0.072 0.016 DBMET02273 0.073 0.015 DBMET02274 0.068 0.023 DBMET02275 | DBMET02274 | |
| 0.03 | 0.005 | 0.035 | Kainate receptor 3 antagonist | 0.035 0.005 DBMET02273 0.032 0.005 DBMET02274 | DBMET02273 | |
| 0.112 | 0.087 | 0.203 | Amylase inhibitor | 0.203 0.043 DBMET02273 0.203 0.043 DBMET02274 0.137 0.071 DBMET02275 | DBMET02274 | |
| 0.067 | 0.042 | 0.101 | Beta adrenoreceptor antagonist | 0.091 0.02 DBMET02273 0.092 0.02 DBMET02274 0.101 0.016 DBMET02275 | DBMET02275 | |
| 0.044 | 0.021 | 0.049 | Membrane dipeptidase inhibitor | 0.049 0.017 DBMET02273 0.046 0.019 DBMET02274 0.041 0.024 DBMET02275 | DBMET02273 | |
| 0.059 | 0.036 | 0.064 | Kallikrein 1 inhibitor | 0.064 0.029 DBMET02273 0.064 0.029 DBMET02274 | DBMET02274 | |
| 0.032 | 0.009 | 0.034 | Complement factor 1r inhibitor | 0.033 0.008 DBMET02273 0.032 0.009 DBMET02274 0.034 0.008 DBMET02275 0.027 0.016 DBMET00559 | DBMET02275 | |
| 0.043 | 0.02 | 0.056 | Arginase inhibitor | 0.056 0.012 DBMET02273 0.053 0.013 DBMET02274 | DBMET02273 | |
| 0.108 | 0.086 | 0.17 | Aldehyde dehydrogenase inhibitor | 0.169 0.037 DBMET02273 0.17 0.037 DBMET02274 0.164 0.04 DBMET02275 | DBMET02274 | |
| 0.043 | 0.021 | 0.049 | Carbonic anhydrase I stimulant | 0.049 0.017 DBMET02273 0.047 0.018 DBMET02274 | DBMET02273 | |
| 0.041 | 0.02 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.017 DBMET02273 0.042 0.017 DBMET02274 0.038 0.026 DBMET02275 | DBMET02274 | |
| 0.029 | 0.009 | 0.042 | Beta 1 adrenoreceptor agonist | 0.041 0.005 DBMET02273 0.042 0.005 DBMET02274 0.032 0.007 DBMET02275 | DBMET02274 | |
| 0.045 | 0.024 | 0.055 | Erythropoietin receptor agonist | 0.055 0.019 DBMET02273 0.053 0.02 DBMET02274 | DBMET02273 | |
| 0.088 | 0.067 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 DBMET02273 0.111 0.046 DBMET02274 0.143 0.028 DBMET02275 | DBMET02275 | |
| 0.033 | 0.013 | 0.037 | Urotensin II agonist | 0.031 0.015 DBMET02273 0.03 0.015 DBMET02274 0.037 0.011 DBMET02275 | DBMET02275 | |
| 0.028 | 0.009 | 0.036 | Integrin alpha4beta7 antagonist | 0.036 0.007 DBMET02273 0.035 0.007 DBMET02274 | DBMET02273 | |
| 0.169 | 0.15 | 0.231 | Calpain inhibitor | 0.227 0.088 DBMET02273 0.231 0.083 DBMET02274 | DBMET02274 | |
| 0.13 | 0.111 | 0.155 | Interferon gamma antagonist | 0.155 0.072 DBMET02273 0.151 0.076 DBMET02274 0.145 0.084 DBMET02275 | DBMET02273 | |
| 0.05 | 0.032 | 0.059 | Aminopeptidase N inhibitor | 0.059 0.025 DBMET02273 0.058 0.025 DBMET02274 | DBMET02273 | |
| 0.041 | 0.024 | 0.061 | Glucagon-like peptide 1 receptor antagonist | 0.061 0.008 DBMET02275 | DBMET02275 | |
| 0.07 | 0.053 | 0.094 | Peroxisome proliferator-activated receptor gamma antagonist | 0.079 0.035 DBMET02273 0.08 0.033 DBMET02274 0.094 0.019 DBMET02275 | DBMET02275 | |
| 0.048 | 0.031 | 0.048 | Thymidylate synthase inhibitor | 0.047 0.031 DBMET02273 0.048 0.03 DBMET02274 0.048 0.03 DBMET02275 | ||
| 0.167 | 0.152 | 0.249 | Hypoglycemic | 0.249 0.078 DBMET02273 0.248 0.078 DBMET02274 0.239 0.084 DBMET02275 | DBMET02273 | |
| 0.034 | 0.02 | 0.041 | Catechol O-methyltransferase inhibitor | 0.039 0.015 DBMET02273 0.038 0.015 DBMET02274 0.041 0.013 DBMET02275 | DBMET02275 | |
| 0.044 | 0.03 | 0.052 | Complement C3a chemotactic receptor antagonist | 0.052 0.026 DBMET02273 0.052 0.026 DBMET02274 | DBMET02274 | |
| 0.038 | 0.024 | 0.118 | Retinoid X receptor agonist | 0.118 0.004 DBMET02275 | DBMET02275 | |
| 0.045 | 0.031 | 0.055 | Beta adrenoreceptor agonist | 0.054 0.012 DBMET02273 0.055 0.011 DBMET02274 0.051 0.016 DBMET02275 | DBMET02274 | |
| 0.05 | 0.036 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.028 DBMET02273 0.055 0.028 DBMET02274 0.053 0.03 DBMET02275 | DBMET02274 | |
| 0.068 | 0.055 | 0.188 | Cathepsin G inhibitor | 0.099 0.033 DBMET02273 0.103 0.032 DBMET02274 0.085 0.04 DBMET02275 0.188 0.017 DBMET00559 | DBMET00559 | |
| 0.047 | 0.034 | 0.053 | Dopamine transporter inhibitor | 0.053 0.029 DBMET02275 | DBMET02275 | |
| 0.051 | 0.038 | 0.053 | Carbonic anhydrase II stimulant | 0.053 0.034 DBMET02273 0.052 0.035 DBMET02274 | DBMET02273 | |
| 0.017 | 0.005 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET02273 0.019 0.004 DBMET02274 | DBMET02273 | |
| 0.064 | 0.052 | 0.074 | Sirtuin 1 inhibitor | 0.074 0.041 DBMET02273 0.072 0.043 DBMET02274 | DBMET02273 | |
| 0.049 | 0.037 | 0.164 | Thromboxane A2 antagonist | 0.045 0.041 DBMET02273 0.046 0.039 DBMET02274 0.164 0.004 DBMET02275 | DBMET02275 | |
| 0.125 | 0.113 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.143 0.074 DBMET02273 0.144 0.072 DBMET02274 0.155 0.053 DBMET02275 | DBMET02275 | |
| 0.106 | 0.095 | 0.147 | Toll-Like receptor 2 antagonist | 0.147 0.054 DBMET02273 0.146 0.055 DBMET02274 0.106 0.095 DBMET02275 | DBMET02273 | |
| 0.026 | 0.015 | 0.05 | Glutamate (mGluR1) agonist | 0.034 0.007 DBMET02273 0.032 0.008 DBMET02274 0.05 0.005 DBMET00559 | DBMET00559 | |
| 0.032 | 0.022 | 0.032 | Somatostatin agonist | |||
| 0.092 | 0.082 | 0.161 | Monophenol monooxygenase inhibitor | 0.154 0.045 DBMET02273 0.161 0.043 DBMET02274 0.1 0.076 DBMET02275 | DBMET02274 | |
| 0.049 | 0.04 | 0.061 | CXC chemokine 1 receptor antagonist | 0.061 0.02 DBMET02275 | DBMET02275 | |
| 0.092 | 0.083 | 0.101 | Folate antagonist | 0.101 0.063 DBMET02273 0.101 0.063 DBMET02274 | DBMET02274 | |
| 0.027 | 0.018 | 0.036 | Lysine carboxypeptidase inhibitor | 0.036 0.012 DBMET02273 0.035 0.013 DBMET02274 | DBMET02273 | |
| 0.12 | 0.112 | 0.463 | Anticoagulant | 0.142 0.088 DBMET02273 0.141 0.089 DBMET02274 0.463 0.012 DBMET00559 | DBMET00559 | |
| 0.127 | 0.119 | 0.162 | Melanin inhibitor | 0.157 0.072 DBMET02273 0.159 0.07 DBMET02274 0.162 0.067 DBMET02275 | DBMET02275 | |
| 0.031 | 0.025 | 0.039 | Prostacyclin antagonist | 0.039 0.019 DBMET02273 0.039 0.019 DBMET02274 | DBMET02274 | |
| 0.019 | 0.014 | 0.025 | Integrin beta7 antagonist | 0.025 0.011 DBMET02273 0.025 0.011 DBMET02274 | DBMET02274 | |
| 0.103 | 0.099 | 0.143 | Cyclooxygenase 3 inhibitor | 0.14 0.057 DBMET02273 0.143 0.054 DBMET02274 | DBMET02274 | |
| 0.058 | 0.053 | 0.072 | Neutrophil collagenase inhibitor | 0.072 0.038 DBMET02273 0.072 0.038 DBMET02274 | DBMET02274 | |
| 0.014 | 0.01 | 0.021 | Integrin beta6 antagonist | 0.016 0.007 DBMET02273 0.016 0.007 DBMET02274 0.021 0.004 DBMET02275 | DBMET02275 | |
| 0.03 | 0.026 | 0.113 | ATP citrate lysase inhibitor | 0.031 0.023 DBMET02273 0.031 0.023 DBMET02274 0.113 0.003 DBMET02275 | DBMET02275 | |
| 0.023 | 0.019 | 0.034 | NMDA receptor glycine site antagonist | 0.031 0.012 DBMET02273 0.028 0.014 DBMET02274 0.034 0.011 DBMET02275 | DBMET02275 | |
| 0.071 | 0.068 | 0.096 | Cell adhesion molecule inhibitor | 0.09 0.042 DBMET02273 0.089 0.043 DBMET02274 0.096 0.038 DBMET00559 | DBMET00559 | |
| 0.049 | 0.046 | 0.057 | Vanilloid 2 antagonist | 0.053 0.035 DBMET02273 0.053 0.034 DBMET02274 0.057 0.027 DBMET02275 | DBMET02275 | |
| 0.086 | 0.083 | 0.113 | Interleukin 12 antagonist | 0.113 0.036 DBMET02273 0.113 0.036 DBMET02274 0.111 0.039 DBMET02275 | DBMET02274 | |
| 0.049 | 0.046 | 0.065 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET02273 0.056 0.033 DBMET02274 0.065 0.021 DBMET00559 | DBMET00559 | |
| 0.039 | 0.038 | 0.049 | Neurotensin receptor antagonist | 0.049 0.029 DBMET02273 0.048 0.029 DBMET02274 | DBMET02273 | |
| 0.05 | 0.049 | 0.061 | Dopamine uptake inhibitor | 0.052 0.047 DBMET02273 0.054 0.045 DBMET02274 0.061 0.037 DBMET02275 | DBMET02275 | |
| 0.047 | 0.046 | 0.169 | Thromboxane antagonist | 0.169 0.004 DBMET02275 | DBMET02275 | |
| 0.066 | 0.067 | 0.086 | Analgesic, opioid | 0.086 0.041 DBMET02273 0.085 0.041 DBMET02274 | DBMET02273 | |
| 0.065 | 0.067 | 0.086 | Metalloproteinase-9 inhibitor | 0.086 0.04 DBMET02273 0.086 0.04 DBMET02274 0.066 0.065 DBMET02275 | DBMET02274 | |
| 0.021 | 0.023 | 0.027 | ICAM 1 antagonist | 0.026 0.01 DBMET02273 0.027 0.009 DBMET02274 | DBMET02274 | |
| 0.014 | 0.017 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DBMET02273 0.018 0.012 DBMET02274 | DBMET02274 | |
| 0.047 | 0.05 | 0.084 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET02273 0.072 0.024 DBMET02274 0.084 0.015 DBMET02275 | DBMET02275 | |
| 0.029 | 0.033 | 0.068 | RNA-directed RNA polymerase inhibitor | 0.043 0.016 DBMET02273 0.068 0.008 DBMET02274 0.031 0.028 DBMET02275 | DBMET02274 | |
| 0.055 | 0.06 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | 0.088 0.032 DBMET02273 0.086 0.033 DBMET02274 0.07 0.044 DBMET02275 | DBMET02273 | |
| 0.02 | 0.025 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 DBMET02273 | DBMET02273 | |
| 0.084 | 0.091 | 0.28 | Ferrochelatase inhibitor | 0.099 0.072 DBMET02273 0.096 0.076 DBMET02274 0.28 0.009 DBMET02275 | DBMET02275 | |
| 0.037 | 0.044 | 0.074 | Sigma receptor antagonist | 0.074 0.022 DBMET02275 | DBMET02275 | |
| 0.079 | 0.086 | 0.167 | Uric acid excretion stimulant | 0.101 0.052 DBMET02273 0.1 0.053 DBMET02274 0.167 0.019 DBMET02275 | DBMET02275 | |
| 0.035 | 0.043 | 0.043 | Endothelin-converting enzyme inhibitor | 0.043 0.036 DBMET02273 0.042 0.036 DBMET02274 | DBMET02273 | |
| 0.031 | 0.039 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.023 DBMET02273 0.041 0.023 DBMET02274 | DBMET02274 | |
| 0.017 | 0.025 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.017 DBMET02273 0.02 0.018 DBMET02274 | DBMET02274 | |
| 0.028 | 0.036 | 0.182 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.027 DBMET02273 0.032 0.027 DBMET02274 0.182 0.004 DBMET02275 | DBMET02275 | |
| 0.038 | 0.046 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.021 DBMET02275 | DBMET02275 | |
| 0.01 | 0.018 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET02273 0.014 0.01 DBMET02274 | DBMET02274 | |
| 0.069 | 0.077 | 0.119 | Glycine receptor antagonist | 0.079 0.059 DBMET02273 0.072 0.071 DBMET02274 0.081 0.055 DBMET02275 0.119 0.019 DBMET00559 | DBMET00559 | |
| 0.047 | 0.055 | 0.064 | Sphingosine kinase 2 inhibitor | 0.062 0.029 DBMET02273 0.064 0.027 DBMET02274 | DBMET02274 | |
| 0.047 | 0.056 | 0.052 | Cathepsin B inhibitor | 0.052 0.046 DBMET02273 0.052 0.046 DBMET02274 | DBMET02274 | |
| 0.024 | 0.034 | 0.062 | HCV NS5B polymerase inhibitor | 0.038 0.015 DBMET02273 0.062 0.008 DBMET02274 | DBMET02274 | |
| 0.065 | 0.075 | 0.086 | Metalloproteinase-2 inhibitor | 0.086 0.047 DBMET02273 0.086 0.047 DBMET02274 | DBMET02274 | |
| 0.007 | 0.017 | 0.013 | Beta 3 adrenoreceptor agonist | 0.013 0.007 DBMET02273 0.013 0.007 DBMET02274 0.011 0.009 DBMET02275 | DBMET02274 | |
| 0.021 | 0.032 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 DBMET02275 | DBMET02275 | |
| 0.07 | 0.081 | 0.088 | Glutathione S-transferase inhibitor | 0.086 0.052 DBMET02273 0.088 0.05 DBMET02274 | DBMET02274 | |
| 0.187 | 0.198 | 0.273 | Apoptosis antagonist | 0.261 0.117 DBMET02273 0.259 0.119 DBMET02274 0.273 0.105 DBMET02275 | DBMET02275 | |
| 0.032 | 0.043 | 0.044 | Dopamine D5 agonist | 0.044 0.023 DBMET02273 0.042 0.025 DBMET02274 | DBMET02273 | |
| 0.036 | 0.048 | 0.054 | Mannosidase inhibitor | 0.044 0.033 DBMET02273 0.043 0.034 DBMET02274 0.054 0.021 DBMET00559 | DBMET00559 | |
| 0.068 | 0.08 | 0.086 | Opioid kappa receptor antagonist | 0.086 0.049 DBMET02273 0.086 0.05 DBMET02274 | DBMET02274 | |
| 0.096 | 0.109 | 0.133 | Estrogen antagonist | 0.114 0.066 DBMET02273 0.114 0.067 DBMET02274 0.133 0.035 DBMET02275 | DBMET02275 | |
| 0.035 | 0.048 | 0.043 | Antimetabolite | 0.043 0.037 DBMET02273 0.042 0.039 DBMET02274 | DBMET02273 | |
| 0.043 | 0.057 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.046 DBMET02273 0.082 0.015 DBMET02275 | DBMET02275 | |
| 0.046 | 0.06 | 0.135 | Biliverdin reductase inhibitor | 0.053 0.048 DBMET02273 0.054 0.048 DBMET02274 0.135 0.011 DBMET02275 | DBMET02275 | |
| 0.028 | 0.042 | 0.037 | Opioid delta receptor agonist | 0.037 0.022 DBMET02273 0.036 0.023 DBMET02274 | DBMET02273 | |
| 0.05 | 0.066 | 0.058 | Matrix metalloproteinase inhibitor | 0.058 0.057 DBMET02273 | DBMET02273 | |
| 0.023 | 0.039 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 DBMET02273 | DBMET02273 | |
| 0.049 | 0.064 | 0.074 | Adenine nucleotide translocase inhibitor | 0.074 0.012 DBMET00559 | DBMET00559 | |
| 0.068 | 0.083 | 0.101 | Histamine N-methyltransferase inhibitor | 0.101 0.045 DBMET02273 0.099 0.047 DBMET02274 | DBMET02273 | |
| 0.025 | 0.041 | 0.041 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET02273 0.032 0.029 DBMET02274 0.041 0.018 DBMET02275 | DBMET02275 | |
| 0.074 | 0.092 | 0.096 | Estrogen-related receptor beta agonist | 0.087 0.047 DBMET02273 0.089 0.043 DBMET02274 0.096 0.03 DBMET02275 | DBMET02275 | |
| 0.028 | 0.049 | 0.615 | Cholecystokinin B agonist | 0.615 0.002 DBMET00559 | DBMET00559 | |
| 0.022 | 0.044 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.006 DBMET00559 | DBMET00559 | |
| 0.076 | 0.098 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 DBMET02273 0.096 0.062 DBMET02274 0.083 0.082 DBMET02275 | DBMET02273 | |
| 0.032 | 0.054 | 0.043 | Thymidine kinase inhibitor | 0.043 0.025 DBMET02275 | DBMET02275 | |
| 0.032 | 0.056 | 0.04 | Plasmin inhibitor | 0.04 0.039 DBMET00559 | DBMET00559 | |
| 0.132 | 0.157 | 0.242 | Aldehyde oxidase inhibitor | 0.242 0.085 DBMET02273 0.238 0.087 DBMET02274 0.202 0.103 DBMET02275 | DBMET02273 | |
| 0.032 | 0.058 | 0.048 | Opioid mu receptor agonist | 0.048 0.03 DBMET02273 0.048 0.031 DBMET02274 | DBMET02274 | |
| 0.069 | 0.095 | 0.08 | Factor XII inhibitor | 0.079 0.068 DBMET02273 0.08 0.066 DBMET02274 | DBMET02274 | |
| 0.014 | 0.04 | 0.036 | Glutamate (mGluR1a) agonist | 0.036 0.007 DBMET00559 | DBMET00559 | |
| 0.039 | 0.065 | 0.067 | Aconitate hydratase inhibitor | 0.067 0.02 DBMET02275 | DBMET02275 | |
| 0.107 | 0.134 | 0.165 | Phospholipase A2 inhibitor | 0.143 0.082 DBMET02273 0.146 0.079 DBMET02274 0.165 0.062 DBMET02275 | DBMET02275 | |
| 0.032 | 0.062 | 0.052 | AMPA receptor antagonist | 0.052 0.029 DBMET02273 0.049 0.032 DBMET02274 | DBMET02273 | |
| 0.046 | 0.077 | 0.06 | Sphingosine kinase inhibitor | 0.058 0.042 DBMET02273 0.06 0.039 DBMET02274 0.06 0.039 DBMET00559 | DBMET00559 | |
| 0.027 | 0.059 | 0.057 | Glycine transporter 2 inhibitor | 0.054 0.028 DBMET02273 0.057 0.026 DBMET02274 | DBMET02274 | |
| 0.035 | 0.07 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.016 DBMET02275 | DBMET02275 | |
| 0.041 | 0.077 | 0.091 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 DBMET02273 0.061 0.038 DBMET02274 0.091 0.02 DBMET02275 | DBMET02275 | |
| 0.069 | 0.105 | 0.081 | NADH dehydrogenase inhibitor | 0.081 0.072 DBMET02275 | DBMET02275 | |
| 0.043 | 0.08 | 0.129 | HIV-1 integrase (3'-Processing) inhibitor | 0.055 0.053 DBMET02275 0.129 0.017 DBMET00559 | DBMET00559 | |
| 0.08 | 0.118 | 0.121 | Alkylator | 0.121 0.067 DBMET02273 0.113 0.075 DBMET02274 | DBMET02273 | |
| 0.14 | 0.178 | 0.221 | Antioxidant | 0.217 0.103 DBMET02273 0.215 0.104 DBMET02274 0.17 0.142 DBMET02275 0.221 0.101 DBMET00559 | DBMET00559 | |
| 0.074 | 0.114 | 0.115 | Electrolyte absorption antagonist | 0.115 0.04 DBMET02275 | DBMET02275 | |
| 0.073 | 0.114 | 0.111 | Anabolic | 0.09 0.078 DBMET02273 0.111 0.049 DBMET02275 0.095 0.07 DBMET00559 | DBMET02275 | |
| 0.13 | 0.171 | 0.206 | Neurotrophic factor enhancer | 0.179 0.1 DBMET02273 0.182 0.096 DBMET02274 0.206 0.071 DBMET02275 | DBMET02275 | |
| 0.039 | 0.081 | 0.071 | Heparanase inhibitor | 0.055 0.032 DBMET02275 0.071 0.011 DBMET00559 | DBMET00559 | |
| 0.012 | 0.057 | 0.025 | Uridine phosphorylase inhibitor | 0.025 0.023 DBMET02275 | DBMET02275 | |
| 0.071 | 0.115 | 0.103 | Carbonic anhydrase III inhibitor | 0.103 0.059 DBMET02273 0.101 0.061 DBMET02274 | DBMET02273 | |
| 0.082 | 0.127 | 0.136 | Caspase 3 inhibitor | 0.109 0.077 DBMET02273 0.108 0.078 DBMET02274 0.136 0.04 DBMET02275 | DBMET02275 | |
| 0.101 | 0.153 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.098 DBMET02273 0.12 0.097 DBMET02274 0.131 0.072 DBMET02275 | DBMET02275 | |
| 0.03 | 0.083 | 0.089 | Plasminogen activator inhibitor antagonist | 0.089 0.012 DBMET02275 | DBMET02275 | |
| 0.01 | 0.063 | 0.025 | Sigma 2 receptor antagonist | 0.025 0.02 DBMET02275 | DBMET02275 | |
| 0.026 | 0.081 | 0.069 | Aldose reductase inhibitor | 0.069 0.028 DBMET02275 | DBMET02275 | |
| 0.119 | 0.174 | 0.159 | ATPase inhibitor | 0.158 0.088 DBMET02273 0.159 0.087 DBMET02274 0.145 0.11 DBMET02275 | DBMET02274 | |
| 0.121 | 0.179 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.14 0.073 DBMET02275 | DBMET02275 | |
| 0.183 | 0.242 | 0.292 | Calcium channel activator | 0.236 0.164 DBMET02273 0.237 0.163 DBMET02274 0.292 0.1 DBMET02275 | DBMET02275 | |
| 0.054 | 0.114 | 0.078 | Carbonic anhydrase VI inhibitor | 0.078 0.06 DBMET02273 0.078 0.06 DBMET02274 0.071 0.07 DBMET02275 | DBMET02274 | |
| 0.033 | 0.094 | 0.082 | Leukotriene B4 antagonist | 0.082 0.015 DBMET02275 | DBMET02275 | |
| 0.069 | 0.131 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.07 DBMET02273 0.09 0.071 DBMET02274 | DBMET02273 | |
| 0.065 | 0.129 | 0.084 | Thioredoxin inhibitor | 0.083 0.075 DBMET02273 0.083 0.074 DBMET02274 0.084 0.074 DBMET02275 | DBMET02275 | |
| 0.031 | 0.096 | 0.123 | HIV-1 integrase (Strand Transfer) inhibitor | 0.123 0.016 DBMET00559 | DBMET00559 | |
| 0.063 | 0.13 | 0.096 | UDP-glucose 4-epimerase inhibitor | 0.096 0.066 DBMET02275 | DBMET02275 | |
| 0.055 | 0.124 | 0.079 | Inducible nitric-oxide synthase inhibitor | 0.079 0.063 DBMET02273 0.078 0.065 DBMET02274 | DBMET02273 | |
| 0.021 | 0.092 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | 0.049 0.021 DBMET02275 | DBMET02275 | |
| 0.009 | 0.08 | 0.033 | Squalene synthetase inhibitor | 0.033 0.022 DBMET02275 | DBMET02275 | |
| 0.057 | 0.131 | 0.073 | GABA B receptor agonist | 0.07 0.068 DBMET02273 0.071 0.066 DBMET02274 0.073 0.059 DBMET02275 | DBMET02275 | |
| 0.011 | 0.085 | 0.031 | Prostaglandin F2 alpha agonist | 0.031 0.008 DBMET02275 | DBMET02275 | |
| 0.044 | 0.119 | 0.059 | Interferon inducer | 0.059 0.056 DBMET02275 | DBMET02275 | |
| 0.05 | 0.126 | 0.077 | Interferon agonist | 0.077 0.058 DBMET02275 | DBMET02275 | |
| 0.098 | 0.177 | 0.332 | Hemostatic | 0.142 0.079 DBMET02273 0.14 0.081 DBMET02274 0.332 0.013 DBMET00559 | DBMET00559 | |
| 0.016 | 0.097 | 0.089 | Urate transporter 1 inhibitor | 0.089 0.006 DBMET02275 | DBMET02275 | |
| 0.036 | 0.117 | 0.051 | Dihydroorotate oxidase inhibitor | 0.051 0.048 DBMET02275 | DBMET02275 | |
| 0.006 | 0.088 | 0.058 | Estrone sulfatase inhibitor | 0.058 0.006 DBMET00559 | DBMET00559 | |
| 0.042 | 0.125 | 0.095 | Thrombin inhibitor | 0.095 0.029 DBMET00559 | DBMET00559 | |
| 0.07 | 0.154 | 0.122 | Bone formation stimulant | 0.122 0.084 DBMET02273 0.12 0.085 DBMET02274 | DBMET02273 | |
| 0.034 | 0.119 | 0.095 | Thromboxane synthase inhibitor | 0.095 0.007 DBMET02275 | DBMET02275 | |
| 0.022 | 0.108 | 0.055 | Sphingosine 1-phosphate receptor agonist | 0.055 0.021 DBMET02275 | DBMET02275 | |
| 0.098 | 0.185 | 0.145 | Anesthetic general | 0.145 0.12 DBMET02273 0.144 0.121 DBMET02274 | DBMET02273 | |
| 0.09 | 0.181 | 0.191 | Arachidonic acid antagonist | 0.191 0.042 DBMET02275 | DBMET02275 | |
| 0.075 | 0.166 | 0.109 | Alkaline phosphatase inhibitor | 0.108 0.102 DBMET02273 0.109 0.102 DBMET02274 | DBMET02274 | |
| 0.093 | 0.186 | 0.121 | Thiol protease inhibitor | 0.121 0.115 DBMET02274 | DBMET02274 | |
| 0.072 | 0.169 | 0.12 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET02273 0.116 0.098 DBMET02274 | DBMET02273 | |
| 0.19 | 0.291 | 0.309 | Calcium channel L-type activator | 0.292 0.164 DBMET02273 0.309 0.15 DBMET02274 0.288 0.168 DBMET02275 | DBMET02274 | |
| 0.025 | 0.127 | 0.062 | GABA receptor antagonist | 0.062 0.031 DBMET02275 | DBMET02275 | |
| 0.008 | 0.112 | 0.049 | Leukotriene B4 receptor 1 antagonist | 0.049 0.007 DBMET02275 | DBMET02275 | |
| 0.141 | 0.245 | 0.169 | Nitric-oxide synthase stimulant | 0.168 0.158 DBMET02273 0.169 0.154 DBMET02274 | DBMET02274 | |
| 0.034 | 0.141 | 0.085 | Purinergic P2X1 antagonist | 0.085 0.022 DBMET02275 | DBMET02275 | |
| 0.058 | 0.165 | 0.106 | Estrogen receptor beta antagonist | 0.106 0.054 DBMET02275 | DBMET02275 | |
| 0.05 | 0.16 | 0.063 | MDM2 inhibitor | 0.063 0.061 DBMET02275 | DBMET02275 | |
| 0.008 | 0.123 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 DBMET02275 | DBMET02275 | |
| 0.032 | 0.15 | 0.075 | Sphingosine 1-phosphate receptor 5 agonist | 0.075 0.014 DBMET02275 | DBMET02275 | |
| 0.039 | 0.157 | 0.068 | Leukotriene C antagonist | 0.068 0.016 DBMET02275 | DBMET02275 | |
| 0.03 | 0.149 | 0.052 | Heme oxygenase inhibitor | 0.052 0.011 DBMET02275 | DBMET02275 | |
| 0.005 | 0.125 | 0.234 | Cholecystokinin B antagonist | 0.234 0.004 DBMET00559 | DBMET00559 | |
| 0.078 | 0.201 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.1 DBMET02274 | DBMET02274 | |
| 0.114 | 0.238 | 0.13 | Heat shock protein 70 antagonist | 0.129 0.125 DBMET02273 0.13 0.123 DBMET02274 | DBMET02274 | |
| 0.031 | 0.156 | 0.102 | Carbonic anhydrase XIII inhibitor | 0.102 0.037 DBMET00559 | DBMET00559 | |
| 0.023 | 0.148 | 0.056 | GABA A receptor antagonist | 0.056 0.034 DBMET02275 | DBMET02275 | |
| 0.01 | 0.135 | 0.062 | Free fatty acid receptor 1 antagonist | 0.062 0.005 DBMET02275 | DBMET02275 | |
| 0.039 | 0.167 | 0.121 | Macrophage migration inhibitory factor inhibitor | 0.121 0.025 DBMET02275 | DBMET02275 | |
| 0.077 | 0.207 | 0.329 | Diuretic | 0.115 0.111 DBMET02273 0.329 0.018 DBMET00559 | DBMET00559 | |
| 0.025 | 0.156 | 0.045 | Leukotriene C4 antagonist | 0.045 0.015 DBMET02275 | DBMET02275 | |
| 0.004 | 0.135 | 0.074 | Free fatty acid receptor 1 agonist | 0.074 0.004 DBMET02275 | DBMET02275 | |
| 0.005 | 0.139 | 0.294 | Cholecystokinin A antagonist | 0.294 0.004 DBMET00559 | DBMET00559 | |
| 0.104 | 0.238 | 0.178 | Vasodilator | 0.178 0.123 DBMET02273 0.174 0.128 DBMET02274 | DBMET02273 | |
| 0.012 | 0.147 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.075 0.02 DBMET02275 | DBMET02275 | |
| 0.117 | 0.257 | 0.158 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.158 0.13 DBMET02275 | DBMET02275 | |
| 0.008 | 0.154 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | 0.056 0.011 DBMET02275 | DBMET02275 | |
| 0.003 | 0.151 | 0.025 | G-protein-coupled receptor 120 agonist | 0.025 0.006 DBMET02275 | DBMET02275 | |
| 0.007 | 0.16 | 0.252 | Cholecystokinin antagonist | 0.252 0.004 DBMET00559 | DBMET00559 | |
| 0.026 | 0.182 | 0.089 | Factor IXa inhibitor | 0.089 0.013 DBMET00559 | DBMET00559 | |
| 0.005 | 0.167 | 0.506 | Cholecystokinin agonist | 0.506 0.002 DBMET00559 | DBMET00559 | |
| 0.004 | 0.166 | 0.032 | Prostaglandin H2 antagonist | 0.032 0.011 DBMET02275 | DBMET02275 | |
| 0.044 | 0.21 | 0.159 | Cholesterol synthesis inhibitor | 0.159 0.04 DBMET02275 | DBMET02275 | |
| 0.024 | 0.19 | 0.076 | Leukotriene synthesis inhibitor | 0.076 0.039 DBMET02275 | DBMET02275 | |
| 0.078 | 0.247 | 0.166 | Interleukin antagonist | 0.166 0.107 DBMET02273 0.165 0.107 DBMET02274 | DBMET02273 | |
| 0.049 | 0.22 | 0.136 | DNA polymerase I inhibitor | 0.136 0.057 DBMET02275 | DBMET02275 | |
| 0.022 | 0.207 | 0.063 | Carbonic anhydrase VA inhibitor | 0.063 0.055 DBMET00559 | DBMET00559 | |
| 0.019 | 0.212 | 0.078 | Carbonic anhydrase V inhibitor | 0.078 0.037 DBMET00559 | DBMET00559 | |
| 0.006 | 0.2 | 0.034 | Prostaglandin agonist | 0.034 0.018 DBMET02275 | DBMET02275 | |
| 0.019 | 0.214 | 0.074 | Leukotriene antagonist | 0.074 0.036 DBMET02275 | DBMET02275 | |
| 0.003 | 0.201 | 0.023 | Prostaglandin E2 agonist | 0.023 0.016 DBMET02275 | DBMET02275 | |
| 0.005 | 0.208 | 0.335 | Cholecystokinin A agonist | 0.335 0.002 DBMET00559 | DBMET00559 | |
| 0.01 | 0.216 | 0.122 | Prostaglandin EP2 antagonist | 0.122 0.014 DBMET02275 | DBMET02275 | |
| 0.015 | 0.221 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00559 | DBMET00559 | |
| 0.127 | 0.34 | 0.278 | Histamine release inhibitor | 0.278 0.136 DBMET02275 | DBMET02275 | |
| 0.008 | 0.226 | 0.057 | Oleamide hydrolase inhibitor | 0.057 0.022 DBMET02275 | DBMET02275 | |
| 0.055 | 0.282 | 0.129 | Interleukin 4 antagonist | 0.129 0.073 DBMET02275 | DBMET02275 | |
| 0.056 | 0.291 | 0.162 | Cell wall synthesis inhibitor | 0.162 0.054 DBMET00559 | DBMET00559 | |
| 0.004 | 0.269 | 0.044 | Prostaglandin EP3 antagonist | 0.044 0.012 DBMET02275 | DBMET02275 | |
| 0.143 | 0.431 | 0.278 | Antiinflammatory | 0.278 0.236 DBMET02275 | DBMET02275 | |
| 0.052 | 0.366 | 0.222 | Platelet adhesion inhibitor | 0.222 0.06 DBMET00559 | DBMET00559 | |
| 0.015 | 0.353 | 0.084 | CDC25A inhibitor | 0.084 0.039 DBMET00559 | DBMET00559 | |
| 0.046 | 0.47 | 0.196 | 12-Lipoxygenase inhibitor | 0.196 0.156 DBMET02275 | DBMET02275 | |
| 0.007 | 0.441 | 0.142 | NMDA 2B receptor antagonist | 0.142 0.009 DBMET00559 | DBMET00559 | |
| 0.021 | 0.553 | 0.178 | Dual specificity phosphatase inhibitor | 0.178 0.069 DBMET00559 | DBMET00559 | |
| 0.017 | 0.58 | 0.179 | Dual specificity phosphatase 3 inhibitor | 0.179 0.074 DBMET00559 | DBMET00559 | |
| 0.014 | 0.649 | 0.146 | Multidrug resistance-associated protein 1 inhibitor | 0.146 0.027 DBMET00559 | DBMET00559 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |